your partner in preclinical research
Header-new-1

Let urosphereestablish the preclinical proof of concept for your drug candidates.

Header-new-3

A new era is beginning for UROSPHERE.

We extend our activities to GASTROENTEROLOGY and ONCOLOGY.

Header-new-2

UROsphere becomes urosphere+

logotype-vector_corporate-H

Your partner in preclinical research

UROSPHERE is a leading Contract Research Organization specializing in preclinical urogenital, gastro-intestinal and oncological pharmacology assays. We provide the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues.

Learn more about us

News & eventS

News // News & Events // May 27 2016

UROSPHERE presented two posters at ERA-EDTA congress

UROSPHERE presented two posters in collaboration with Solid Drug Development at the 53rd annual ERA-EDTA congress: Effect of JNK inhibitor in a rat model of renal ischemia-reperfusion...

Read more

Events // News & Events // Feb 12 2016

UROSPHERE will be present at the European Association of Urology congress 2016

UROSPHERE will present two posters at the 31st annual EAU congress (13 March 2016 at 12:45 PM, room 14a)

Read more

Events // News & Events // Jan 27 2016

UROSPHERE will attend the toulouse oncoweek, to be held in toulouse, france, february...

We will have an oral communication on "Optical imaging in preclinical tumour models: helpful or pitfall?”

Read more

News // News & Events // Jan 22 2016

UROSPHERE and Ambiotis sign a strategic collaboration agreement

UROSPHERE and Ambiotis another Contract Research Organization, based in Toulouse, France announce a strategic partnership to broaden and strenghten their respective activities. Under...

Read more

News // News & Events // Jan 08 2016

Season's Greetings and Best Wishes!

Best wishes from UROSPHERE for a great year 2016 !

Read more
All news

Publications

Nephrology // Publications // May 27 2016

[Poster] Effects of JNK inhibitor on puromycin aminonucleoside-induced nephropathy...

Chiara Alfarano, Marc Guerard, Claire Abadie, Catherine Deloche, Jean-Marc Combette, Philippe Lluel

53rd ERA-EDTA Congress, May 21st-24th, 2016, Vienna, Austria

Read more

Nephrology // Publications // May 27 2016

[Poster] Effect of JNK inhibitor in a rat model of renal ischemia-reperfusion injury

Chiara Alfarano, Marc Guerard, Claire Abadie, Catherine Deloche, Jean-Marc Combette, PhilippeLluel

53rd ERA-EDTA Congress, May 21st-24th, 2016, Vienna, Austria

Read more

Publications // Urology // Mar 17 2016

[Poster] Immunotherapy to treat Bladder Painful Syndrome

Céline Augé, Philippe Lluel, Nathalie Vergnolle, Gilles Dietrich

31st Annual EAU Congress, 11 -15 March 2016, Munich, Germany

Read more

Publications // Urology // Mar 17 2016

[Poster] Development and validation of clinically-relevant chronic model of IC/BPS

Sophie Chabot , Céline Augé, Murielle Meen, Véronique Guilloteau, Nathalie Vergnolle, Xavier Gamé and Philippe Lluel

31st Annual EAU Congress, 11 -15 March 2016, Munich,...

Read more

Oncology // Publications // Jan 19 2016

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen...

Legrier ME, Bièche I, Gaston J, Beurdeley A, Yvonnet V, Déas O, Thuleau A, Château-Joubert S, Servely JL, Vacher S, Lassalle M, Depil S, C Tucker G, Fontaine JJ, Poupon MF, Roman-Roman...

Read more
All publications